OliX PharmaceuticalsInc (226950) - Total Liabilities

Latest as of December 2025: ₩45.29 Billion KRW ≈ $30.69 Million USD

Based on the latest financial reports, OliX PharmaceuticalsInc (226950) has total liabilities worth ₩45.29 Billion KRW (≈ $30.69 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

OliX PharmaceuticalsInc - Total Liabilities Trend (2016–2025)

This chart illustrates how OliX PharmaceuticalsInc's total liabilities have evolved over time, based on quarterly financial data. See OliX PharmaceuticalsInc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

OliX PharmaceuticalsInc Competitors by Total Liabilities

The table below lists competitors of OliX PharmaceuticalsInc ranked by their total liabilities.

Company	Country	Total Liabilities
Hunan Nanling Industrial Explosive Materials Co Ltd SHE:002096	China	CN¥3.87 Billion
Zhewen Interactive Group Co Ltd SHG:600986	China	CN¥4.32 Billion
Nexa Resources SA NYSE:NEXA	USA	$3.99 Billion
Anhui Kouzi Distillery Co Ltd SHG:603589	China	CN¥2.23 Billion
Voyager Technologies, Inc. NYSE:VOYG	USA	$619.25 Million
Triputra Agro Persada Tbk PT JK:TAPG	Indonesia	Rp2.95 Trillion
Topscore Fashion SHG:603608	China	CN¥357.21 Million
Dynavax Technologies Corporation NASDAQ:DVAX	USA	$412.37 Million

Liability Composition Analysis (2016–2025)

This chart breaks down OliX PharmaceuticalsInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is OliX PharmaceuticalsInc worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.30	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how OliX PharmaceuticalsInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for OliX PharmaceuticalsInc (2016–2025)

The table below shows the annual total liabilities of OliX PharmaceuticalsInc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩45.29 Billion ≈ $30.69 Million	-15.19%
2024-12-31	₩53.40 Billion ≈ $36.19 Million	+1.74%
2023-12-31	₩52.49 Billion ≈ $35.57 Million	-21.36%
2022-12-31	₩66.74 Billion ≈ $45.23 Million	-2.06%
2021-12-31	₩68.15 Billion ≈ $46.18 Million	+104.71%
2020-12-31	₩33.29 Billion ≈ $22.56 Million	+876.59%
2019-12-31	₩3.41 Billion ≈ $2.31 Million	+387.74%
2018-12-31	₩698.94 Million ≈ $473.66K	-76.42%
2017-12-31	₩2.96 Billion ≈ $2.01 Million	+14.35%
2016-12-31	₩2.59 Billion ≈ $1.76 Million	--

About OliX PharmaceuticalsInc

KQ:226950 Korea Biotechnology

Market Cap

$1.76 Billion

₩2.60 Trillion KRW

Market Cap Rank

#6741 Global

#177 in Korea

Share Price

₩129300.00

Change (1 day)

+7.04%

52-Week Range

₩34800.00 - ₩207000.00

All Time High

₩207000.00